The number of people with susceptibility test result for rifampicin in Brunei Darussalam

Brunei Darussalam: The number of people with susceptibility test result for rifampicin was 162 in 2021. ▬ Flat

Latest (2021)
162
Change on year
down 29.3%
World rank
99th
of 155 countries
All-time high
229
in 2020
All-time low
162
in 2021
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Brunei Darussalam, 2017–2021

0501001502002502017201920212017: 1702018: 1972019: 1942020: 2292021: 162

Source: World Health Organization, Global Health Observatory.

Analysis

In 2021, the number of people with susceptibility test result for rifampicin in Brunei Darussalam stood at 162. That is the lowest value across all 5 years on record.

The figure is down 29.3% on the previous year and down 4.7% over five years.

Brunei Darussalam ranks 99th of 155 countries on this measure, in the middle of the range.

The number of people with susceptibility test result for rifampicin in Brunei Darussalam, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Brunei Darussalam, 2017 to 2021.
Year Value Change
2017 170
2018 197 +15.9%
2019 194 -1.5%
2020 229 +18.0%
2021 162 -29.3%

Brunei Darussalam compared with similar countries

  • Brunei Darussalam's 162 is above the median for high income countries, which is 142, 1.1× the median. (61 countries reporting)
  • Brunei Darussalam's 162 is below the median for East Asia & Pacific, which is 185, 88% of the median. (28 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 187 170 197 3
2020s 195.5 162 229 2

Countries ranked near Brunei Darussalam

  1. 96 Kiribati 177 compare
  2. 97 Sweden 173 compare
  3. 98 Austria 165 compare
  4. 100 Bulgaria 156 compare
  5. 101 Albania 154 compare
  6. 102 Oman 144 compare

See the full ranking of 157 places →

More health data for Brunei Darussalam

All data for Brunei Darussalam →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Brunei Darussalam?
The number of people with susceptibility test result for rifampicin in Brunei Darussalam was 162 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Brunei Darussalam?
The highest recorded value was 229 in 2020.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Brunei Darussalam?
The lowest recorded value was 162 in 2021.
How does Brunei Darussalam rank for the number of people with susceptibility test result for rifampicin?
Brunei Darussalam ranks 99th out of 155 countries with data for 2021.
Where does this Brunei Darussalam data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Brunei Darussalam. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 16 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/brunei-darussalam/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/brunei-darussalam/">The number of people with susceptibility test result for rifampicin in Brunei Darussalam</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed